{"organizations": [], "uuid": "5d0030be3ac1a3c029395d588186e4995b4aa775", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180409.html", "section_title": "Archive News &amp; Video for Monday, 09 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/novartis-avexis/novartis-shells-out-8-7-bln-to-buy-avexis-idUSFWN1RM02T", "country": "US", "domain_rank": 408, "title": "Novartis shells out $8.7 bln to buy AveXis", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-09T12:59:00.000+03:00", "replies_count": 0, "uuid": "5d0030be3ac1a3c029395d588186e4995b4aa775"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/novartis-avexis/novartis-shells-out-8-7-bln-to-buy-avexis-idUSFWN1RM02T", "ord_in_thread": 0, "title": "Novartis shells out $8.7 bln to buy AveXis", "locations": [], "entities": {"persons": [], "locations": [{"name": "zurich", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "novartis", "sentiment": "negative"}, {"name": "glaxosmithkline", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "ZURICH, April 9 (Reuters) - Novartis said on Monday it plans to buy AveXis for $218 per share in a cash deal totaling $8.7 billion as the Swiss drugmaker adds a company whose top drug hopeful, for spinal muscular atrophy, has U.S. breakthrough therapy designation.\nNovartis is flush with cash, having just agreed to sell its stake in a consumer healthcare joint venture for $13 billion to GlaxoSmithKline. (Reporting by)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-09T12:59:00.000+03:00", "crawled": "2018-04-10T12:35:07.006+03:00", "highlightTitle": ""}